Bill Text: NY A02538 | 2017-2018 | General Assembly | Introduced


Bill Title: Establishes the clinical trial access and education fund to provide grants to eligible applicants to provide certain services for patients with life-threatening or disabling conditions or diseases.

Spectrum: Partisan Bill (Democrat 19-0)

Status: (Introduced - Dead) 2018-01-03 - referred to ways and means [A02538 Detail]

Download: New_York-2017-A02538-Introduced.html


                STATE OF NEW YORK
        ________________________________________________________________________
                                          2538
                               2017-2018 Regular Sessions
                   IN ASSEMBLY
                                    January 20, 2017
                                       ___________
        Introduced  by  M.  of A. GOTTFRIED, PAULIN, GUNTHER, ROSENTHAL, CAHILL,
          GALEF,  ENGLEBRIGHT,  JAFFEE,  ZEBROWSKI,  HOOPER,  LUPARDO,   TITONE,
          ABINANTI,  PERRY,  WEPRIN,  KEARNS, McDONALD, SEPULVEDA -- Multi-Spon-
          sored by -- M.  of A. CARROLL -- read once and referred to the Commit-
          tee on Health
        AN ACT to amend the public health law, in relation to  establishing  the
          clinical trial access and education fund
          The  People of the State of New York, represented in Senate and Assem-
        bly, do enact as follows:
     1    Section 1. The public health law is amended by adding  a  new  section
     2  2424 to read as follows:
     3    § 2424. Clinical trial access and education fund. 1. Definitions.  For
     4  the purposes of this section, the following terms shall have the follow-
     5  ing meanings:
     6    a.  "Eligible  applicant"  means  (i) a medical school that sponsors a
     7  clinical trial, (ii) a not-for-profit organization with  experience  and
     8  expertise  working  with  patients  with  life-threatening  or disabling
     9  conditions or diseases, (iii) a health care provider organization, asso-
    10  ciation or society, (iv) a general hospital defined in  article  twenty-
    11  eight of this chapter, (v) a county or city health department, or (vi) a
    12  municipality.
    13    b.  "Clinical  trial"  shall  have  the same meaning as in subdivision
    14  two-b of section forty-nine hundred of this chapter.
    15    2. Establishment of fund.  There  is  hereby  established  within  the
    16  department a clinical trial access and education fund. Subject to appro-
    17  priations, the department shall provide grants to eligible applicants on
    18  a  competitive  request for proposal basis to provide one or more of the
    19  following services to patients with life-threatening or disabling condi-
    20  tions or diseases, as such  terms  are  defined  in  section  forty-nine
    21  hundred  of  this chapter, to facilitate access to or education on clin-
    22  ical trials of treatments for the patient's condition or disease:
         EXPLANATION--Matter in italics (underscored) is new; matter in brackets
                              [ ] is old law to be omitted.
                                                                   LBD02083-01-7

        A. 2538                             2
     1    a. transportation services and lodging to provide patients with access
     2  to clinical trials or other related treatments while enrolled in a clin-
     3  ical trial or to access testing and other services to determine  patient
     4  eligibility for a clinical trial;
     5    b.  patient outreach and education services to educate patients, their
     6  families and health care  providers  about  the  existence  of  and  how
     7  patients  may enroll in clinical trials, under section two hundred seven
     8  of this chapter; and
     9    c. patient navigation services to help patients to determine  if  they
    10  are eligible for clinical trials, to help patients to enroll in clinical
    11  trials  and to assist patients in dealing with insurance or other issues
    12  which serve as barriers to patient enrollment in clinical trials.
    13    3. Applications. The commissioner shall establish an application proc-
    14  ess by which eligible applicants  may  apply  for  a  grant  under  this
    15  section.  The application shall include:
    16    a. the geographic area in which the services shall be provided;
    17    b. a detailed description of the services to be provided;
    18    c.  applicant's experience working with patients with life-threatening
    19  or disabling conditions or diseases;
    20    d. applicant's ability to provide patient outreach or  clinical  trial
    21  education  and navigation services, or coordinate or provide transporta-
    22  tion and lodging for patients; and
    23    e. any other information that  the  commissioner  deems  relevant  and
    24  appropriate.
    25    The commissioner shall give preference to eligible applicants who have
    26  experience  and expertise working with patients with life-threatening or
    27  disabling conditions or diseases and providing patient outreach,  educa-
    28  tion and health care navigation services.
    29    4.  Reports. Grantees shall file an annual report with the commission-
    30  er, in such form and with such information and data as the  commissioner
    31  prescribes  detailing the expenditure of grant funds and summarizing the
    32  efforts undertaken to increase patient access to clinical trials.
    33    5. The commissioner shall make  regulations  reasonably  necessary  to
    34  implement the provisions of this section.
    35    § 2. This act shall take effect immediately.
feedback